The Bernese pilot trial for the regulated sale of cannabis in pharmacies will be able to start. The Federal Office of Public Health (OFSP), the Cantonal Ethics Commission and the Ethics Commission of North-West and Central Switzerland have issued the necessary authorisations, reports the RTS.*
The pilot trial and the follow-up study aim to assess the health and social effects of selling cannabis in “strictly regulated and non-profit” pharmacies, recalls Reto Auer, project manager at the University of Bern, quoted Wednesday in a press release from the university.*
The study will be conducted in the cities of Bern, Biel and Lucerne. It should start “probably in the fall”. It is planned to recruit 1091 participants, including about 600 in the federal city, specifies the latter.*
People who regularly use cannabis for recreational purposes and who are at least 18 years old can participate in the study.*
Similar studies have already been authorized in Basel, Zurich, Lausanne and Geneva.*
*** ndlr. : –.